Your session is about to expire
← Back to Search
Electrophysiology Device
Optical Coherence Tomography (OCT) for Glaucoma
N/A
Recruiting
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial compares two eye-testing devices to measure vision in those with normal sight, glaucoma, and retinal diseases.
Eligible Conditions
- Glaucoma
- Normal
- Retinal Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Limit of Agreement (LOA) between the P200TE and predicate device measurements of full retinal thickness.
Limit of Agreement (LOA) between the P200TE and predicate device measurements of ganglion cell complex thickness (μm).
Limit of Agreement (LOA) between the P200TE and predicate device measurements of optic disc (disc area, rim area, cup-to-disc area, cup-to-disc vertical, cup-to-disc horizontal)
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Optical Coherence Tomography (OCT)Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370
Find a Location
Who is running the clinical trial?
Optos, PLCLead Sponsor
17 Previous Clinical Trials
3,390 Total Patients Enrolled
6 Trials studying Glaucoma
378 Patients Enrolled for Glaucoma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still opportunity for patient enrollment in this research project?
"Affirmative. Data hosted on the website clinicaltrials.gov verifies that this medical experiment, which was initially posted on November 4th 2022, is presently recruiting patients. Approximately 125 people need to be enrolled from a single site."
Answered by AI
How many individuals can potentially participate in this experiment?
"Affirmative. Clinicaltrials.gov indicates that this trial, initially initiated on November 4th 2022, is still recruiting participants. 125 individuals are required to participate from a single medical centre."
Answered by AI
Share this study with friends
Copy Link
Messenger